Amplity Health, one of the world’s leading pure-play pharmaceutical commercialization organizations with a reputation as a true partner for its clients, announced the election of Anthony C. Hooper, former Executive Vice President of Global Commercial Operations at Amgen, to its board of directors.
Hooper will leverage his extensive pharmaceutical commercialization experience, along with his passion for patient-first strategies, to guide Amplity as it continues to disrupt the industry with transformational commercial solutions.
“I began working in the pharma space 40 years ago because I wanted to improve people’s health. Amplity is committed to the same mission and is building a company that helps its clients break away from the status quo and think differently about how to engage and educate healthcare professionals, payors, patients, and caregivers. One example of this build-out is the addition of Amplity Insights (formerly RealHealthData). I am looking forward to helping the team at Amplity find and add these types of leading-edge capabilities that both stand alone and improve Amplity’s existing capabilities,” stated Hooper when asked why he was drawn to Amplity.
“We are really pleased to add an executive with such a distinguished track record of successfully commercializing drugs around the world. Tony’s experience and expertise will help us to build out our strategy and to serve clients at a higher level,” commented Michael Griffith, Chief Executive Officer of Amplity Health.
Hooper served as executive vice president of Global Commercial Operations for Amgen Inc. from Oct 2011 to August 2018. During his tenure, he led the evolution of Amgen's commercial organization, placing a relentless focus on putting patients at the center of all the company’s activities. This led to an increase in revenue of 50% and geographic expansion from 48 countries to 102. Prior to joining Amgen, Hooper spent more than 15 years at Bristol-Myers Squibb. His last role there was senior vice president, Global Commercial Operations, and president of the company’s $15 billion pharmaceutical business in the Americas, Japan and Intercontinental regions. Previously, Hooper was assistant vice president of Global Marketing for Wyeth Laboratories and led the international marketing group for Lederle International. Hooper earned law and MBA degrees from the University of South Africa.
About Amplity Health
A true partner to global healthcare companies, Amplity builds transformational solutions by challenging boundaries and the status quo. Amplity has the expertise, infrastructure, and insights to help clients overcome any healthcare commercialization hurdle. With wide-ranging capabilities such as patient identification solutions, multichannel messaging, inside sales and service resourcing, field sales, campaign planning and execution, and more, Amplity has what it takes to maximize marketing efforts and set strategies up for success. For more information, visit amplity.com or follow @amplityhealth on Twitter and LinkedIn at www.linkedin.com/company/amplity-health.
About Altamont Capital Partners
Altamont Capital Partners is a private investment firm based in the San Francisco Bay Area with more than $2.5 billion of assets under management. Altamont is focused on investing in middle-market businesses where it can partner with leading management teams to help its portfolio companies reach their full potential. The firm’s principals have significant experience building business success stories across a range of industries, including healthcare, consumer/retail, industrials, and financial services.